Results of a Phase I Clinical Safety Trial using a child’s own cord blood were recently published, and are giving families and researchers hope. Read More
Autism, a disorder that appears in the first three years of life, affects the brain’s development and impacts social and communication skills.1 While the exact causes of Autism Spectrum Disorder (ASD) are unknown, research suggests that both genes and environment play important roles.2 Read More
During November, individuals and organizations across the country are spreading awareness about premature births for Prematurity Awareness Month. As part of honoring Prematurity Awareness Month, we would like to take a minute to thank all of the researchers, medical professionals and organizations around the world that dedicate their time and extraordinary effort to help prevent premature births and improve the lives of premature babies and their families. Read More
Autism is a disorder that appears during the first three years of life and affects normal development of the brain’s social and communication skills.1 The exact causes of Autism Spectrum Disorder (ASD) are unknown, but research suggests that a combination of genes and environmental factors both play an important role.2 While we don’t know what causes ASD, we do know that it affects 1 in 68 children in the United States – a 30% increase from 2012 when it affected 1 in 88.3 Read More
“Game Changers: Using Cord Blood to Help the Brain” presented by Dr. Joanne Kurtzberg
The 2015 AABB annual meeting has been going on since Saturday, but today is the day we’ve been waiting for! Today, October 26th, Mediware and Save The Cord Foundation will be hosting an exclusive Share the Science presentation about new cord blood clinical applications being researched for treatment of acquired and genetic brain injuries. Read More
ViaCord Speaker Spotlight
Therapeutic Potential of Heterogeneous Cells Isolated Directly from Cord Tissue
Morey Kraus, Chief Scientific Officer
The International Society for Cellular Therapy (ISCT) is a global society of clinicians, regulators, technologists, and industry partners with a shared vision to translate cellular therapy into safe and effective therapies to improve patients’ lives. Each year ISCT gathers for an annual meeting that brings great minds together to share work and progress toward advancing therapies for the benefit of patients worldwide.
This year, over 1200 international delegates are expected to be in attendance at the 21st annual ISCT meeting. Attendees can expect to hear from clinicians, laboratory professionals, industry leaders from cellular therapy companies, and ViaCord’s very own Chief Scientific Officer, Morey Kraus! Not only is Morey part of the speaker program, he – along with a team from ViaCord – will also have an abstract poster on display.